Risk of drug-related problems for various antibiotics in hospital: assessment by use of a novel method

Hege Salvesen Blix1, Kirsten K Viktil, Tron Anders Moger

  • 1Lovisenberg Diakonale Hospital, Oslo, Norway. hege.salvesen.blix@fhi.no

Abstract

Insights

Antibiotic-associated drug-related problems (DRPs) are common in hospitalized patients. A new drug risk ratio highlights significant variations in antibiotic risks, aiding clinical practice awareness.

Area of Science:

  • Clinical Pharmacy
  • Infectious Diseases
  • Pharmacovigilance

Background:

  • Antibiotic use is prevalent in hospital settings.
  • Drug-related problems (DRPs) are a significant concern in patient care.
  • Quantifying antibiotic-specific risks is crucial for safe prescribing.

Purpose of the Study:

  • To investigate antibiotic utilization in hospitals.
  • To identify and analyze drug-related problems (DRPs) associated with antibiotic use.
  • To introduce a novel metric, the drug risk ratio, for assessing antibiotic-related risks.

Main Methods:

  • Prospective study of internal medicine patients across four Norwegian hospitals in 2002.
  • Collection of patient demographics, medication data, medical history, and laboratory results.
  • Identification and assessment of DRPs by clinical pharmacists and multidisciplinary teams.
  • Definition and calculation of the drug risk ratio: DRPs per antibiotic use.

Main Results:

  • 42% of 668 patients used antibiotics; these patients were older and had more DRPs.
  • Most frequent DRP categories included 'no further need for drug', 'non-optimal drug', and 'non-optimal dose'.
  • Drug risk ratios varied significantly across antibiotic classes, with aminoglycosides (0.77) and beta-lactamase-resistant penicillins (0.56) being highest, and cephalosporins (0.17-0.13) lowest.

Conclusions:

  • Antibiotic-associated DRPs are frequent in hospitalized patients.
  • The drug risk ratio demonstrates a six-fold variation in risk among antibiotic groups.
  • A high drug risk ratio signals antibiotics requiring heightened clinical vigilance.

Related Concept Videos

Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...